Cyclofluidic is using CyclOps™, its proprietary closed-loop structure activity platform, to revolutionise hit and lead optimisation. CyclOps™ connects chemistry, purification/analysis, screening and compound design with complex algorithms allowing drug lead molecules to be assayed within minutes, rather than weeks, after they are designed. When combined with the power of flow chemistry, developed in the labs of Prof Steve Ley at Cambridge University, our unique approach puts synthesis, screening and molecular design firmly back together in a single laboratory allowing fast iterative exploration of vast areas of diverse chemical space. CyclOps™ is the ultimate lean approach to lead discovery, allowing Cyclofludic to optimise hits in real time, making and screening only those key compounds that progress a hypothesis towards the best possible lead molecules.

Contact Information

Welwyn Garden City
United Kingdom

Overview

Total FundingEmployeesLast Funding DateStatus
11-50Operating